Clinical trials: Primary Amenorrhoea

Primary Amenorrhea With Hypogonadotropic Hypogonadism

LutrePulse Hypogonadotropic Hypogonadism

• Completed
• Age: 18 to 40 years
• Phase 3
• Injection or infusion
• Results posted

To compare the ovulation rate in women with primary amenorrhea with hypogonadotropic hypogonadism following pulsatile gonadotropin-releasing hormone (GnRH) treatment using the OmniPod pump versus placebo

Trial name

NCT01976728

Testing

Gonadorelin acetate subcutaneous (SC) 10 μg/pulse as a fixed dose, administered via. OmniPod pump, Gonadorelin acetate SC 15 μg/pulse as a fixed dose, administered via. OmniPod pump, Gonadorelin acetate SC 20 μg/pulse as a fixed dose, administered via. OmniPod pump

Where

35 sites in United States, Canada

Volunteers

39 people

Sponsor

Ferring Pharmaceuticals